Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6995165
Reference Type
Journal Article
Title
Immune response to vaccine adjuvants during the first year of life
Author(s)
Levy, O; Goriely, S; Kollmann, TR
Year
2013
Is Peer Reviewed?
1
Journal
Vaccine
ISSN:
0264-410X
EISSN:
1873-2518
Volume
31
Issue
21
Page Numbers
2500-2505
DOI
10.1016/j.vaccine.2012.10.016
Web of Science Id
WOS:000320143200004
Abstract
Subunit vaccine formulations often include adjuvants that primarily stimulate innate immune cells. While young infants represent the major target population for vaccination, effective immunization in this age group remains a challenge. Many parameters of innate immune responses differ quantitatively and qualitatively from newborns to infants and adults, revealing a highly regulated developmental program. Herein, we discuss the potential implications of innate immune ontogeny for the activity of adjuvants contained in licensed infant vaccines, as well as future directions for rational design of adjuvanted vaccines for this age group. (C) 2012 Elsevier Ltd. All rights reserved.
Keywords
Adjuvants; Innate immunity; Vaccines; Newborn; Infant; Immunization
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity